These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2518675)

  • 1. Test models to determine potential ocular drug induced side effects.
    Lerman S
    Lens Eye Toxic Res; 1989; 6(1-2):1-36. PubMed ID: 2518675
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo and in vitro non invasive studies on the ocular lens.
    Lerman S
    Lens Eye Toxic Res; 1989; 6(4):503-14. PubMed ID: 2487267
    [No Abstract]   [Full Text] [Related]  

  • 3. [A model of diffusion of anti-cataract drugs into the lens tissue].
    Chasovnikova LV; Formaziuk VE; Sergienko VI; Vlasimirov IuA
    Biofizika; 1990; 35(3):464-8. PubMed ID: 2207189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for potential in vivo phototoxicity in the lens/retina.
    Roberts JE; Dillon J
    Lens Eye Toxic Res; 1990; 7(3-4):655-66. PubMed ID: 2100184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naproxen: an aldose reductase inhibitor and potential anti-cataract agent.
    Gupta SK; Joshi S
    Dev Ophthalmol; 1991; 21():170-8. PubMed ID: 1907931
    [No Abstract]   [Full Text] [Related]  

  • 6. Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation.
    Zhang J; Guan P; Wang T; Chang D; Jiang T; Wang S
    J Pharm Pharmacol; 2009 Sep; 61(9):1171-8. PubMed ID: 19703366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyceraldehyde is present in rat lens and its level is increased in diabetes mellitus.
    Miwa I; Chen AS; Taguchi T
    Ophthalmic Res; 2009; 41(2):98-101. PubMed ID: 19122471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservative treatment of cataract].
    Mal'tsev EV
    Oftalmol Zh; 1984; (7):430-4. PubMed ID: 6396559
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of curcumin on galactose-induced cataractogenesis in rats.
    Suryanarayana P; Krishnaswamy K; Reddy GB
    Mol Vis; 2003 Jun; 9():223-30. PubMed ID: 12802258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of polyol pathways in formation of diabetic cataracts].
    Sabasiński K; Andrzejewska-Buczko J
    Klin Oczna; 1997; 99(6):401-4. PubMed ID: 9685789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between aldose reductase inhibiting activity and anti-cataract action of various non-steroidal anti-inflammatory drugs.
    Gupta SK; Joshi S
    Dev Ophthalmol; 1991; 21():151-6. PubMed ID: 1907930
    [No Abstract]   [Full Text] [Related]  

  • 13. Photodynamics of cataract: an update on endogenous chromophores and antioxidants.
    Balasubramanian D
    Photochem Photobiol; 2005; 81(3):498-501. PubMed ID: 15623354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accumulation of myoinositol and rubidium ions in galactose-exposed rat lens.
    Kawaba T; Cheng HM; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1522-6. PubMed ID: 3019919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced cataract in chick embryo monitored by Raman spectroscopy.
    Mizuno A; Nishigori H; Iwatsuru M
    Invest Ophthalmol Vis Sci; 1989 Jan; 30(1):132-7. PubMed ID: 2912907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cataract prevention. Therapeutic approaches and critical review of current status].
    Wegener A
    Ophthalmologe; 2003 Mar; 100(3):176-80. PubMed ID: 12640545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to TGFbeta2-induced cataract increases with aging in the rat.
    Hales AM; Chamberlain CG; McAvoy JW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3544-51. PubMed ID: 11006250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photoluminescence of ocular lenses].
    Balter A; Bieganowski L; Marszałek T
    Klin Oczna; 1988; 90 Suppl():471-3. PubMed ID: 3079497
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical aspirin provides protection against galactosemic cataract.
    Gupta SK; Joshi S; Tandon R; Mathur P
    Indian J Ophthalmol; 1997 Dec; 45(4):221-5. PubMed ID: 9567017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.